Since the Albanese Government's landmark $792.9 million women's health package more than 805,000 women have accessed more than 3 million cheaper scripts for new contraceptives, menopausal hormone therapies and endometriosis treatment through the Pharmaceutical Benefits Scheme (PBS).
Today marks one year since the Albanese Government listed oral contraceptive Slinda ® (drospirenone) and endometriosis treatment Ryeqo® (relugolix + estradiol + norethisterone acetate) onto the PBS.
In 2025 the Albanese Government listed four new contraceptives on the PBS resulting in more than 382,000 women saving $36.0 million on over 854,000 cheaper scripts.
Slinda® before listing on the PBS cost women $250 per year, now only costs a maximum of $25 per script or $7.70 with a concession card.
More than 8,500 women living with endometriosis have accessed around 40,000 cheaper scripts for Ryeqo®, previously costing $2,700 per year now saving them a total of $7.6 million.
This record investment into women's health is delivering more choice, lower costs and better health care for women.
Quotes attributable to Assistant Minister White:
"The Albanese Government's Women's Health Package is delivering more choice, lower costs and better access to healthcare for women.
"Women told us they were left hundreds of dollars out of pocket for basic contraceptive scripts and couldn't access support for menopause and endometriosis, so we've changed that.
"The value of the PBS cannot be overstated. These are important women's health medicines - and their listing is giving women more control over their health.
"These results show our record investment in women's health is working, with thousands of women saving money and getting better access to the care they need and deserve.
"I am proud to be part of a government that is giving such unparalleled focus to women's health - and harnessing the power of the PBS to ensure women have affordable access to treatments by making medicines cheaper."
Quotes attributable to Genevieve Rapson, 27, Melbourne:
"I started taking Slinda to manage my PMS symptoms, which were significantly affecting my daily life. After just two months, the difference has been remarkable.
"When I was deciding whether to try Slinda, knowing it was on the PBS made all the difference. The cost of being a woman adds up, and finally, the low cost makes managing my health accessible. I no longer have to justify investing in my own wellbeing."
